SUBSCRIBE
SUBSCRIBE
News   Drug Development

Study Backs Roche Holding AG’s (JOBS) New Use of Avastin Cancer Drug

August 18, 2009 | 
1 min read
Bookmark and Share

Reuters -- Swiss-based Roche Holding AG said on Tuesday a study had showed its drug Avastin increased life expectancy for women with breast cancer without the disease getting worse, when used alongside common chemotherapies.
Clinical research Phase III Europe
MORE ON THIS TOPIC
Vaccines
Quick on Its Feet: Novavax Adapts to Continued Regulatory Uncertainty
June 20, 2025
 · 
3 min read
 · 
Heather McKenzie
Contemporary art collage. employee mowing forward to success, stepping ladder of professional growth. Concept of business.
Obesity
Scholar Rock Jumps on Weight Loss Data for Zepbound/Repurposed Antibody Combo
June 18, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
3d illustration of a black dragon flying on an extraterrestrial world with mountains beneath.
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Goal concept. Human hand in dotted pop art style pointing on the target for red paper plane. Vector illustration
Approvals
CSL Wins First Approval for Preventive Hereditary Angioedema Drug
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac